What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His primary areas of study are Transplantation, Internal medicine, Kidney transplantation, Pharmacology and Urology.
His Transplantation study incorporates themes from Kidney and Immunology.
His research integrates issues of Gastroenterology, Placebo and Endocrinology in his study of Internal medicine.
Surgery covers Klemens Budde research in Kidney transplantation.
His Surgery research is multidisciplinary, incorporating elements of Immunosuppression and Incidence.
His study in Urology is interdisciplinary in nature, drawing from both Renal function, Survival rate, Autosomal dominant polycystic kidney disease, Basiliximab and Everolimus.
His most cited work include:
- Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. (626 citations)
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial (515 citations)
- Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. (459 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Transplantation, Internal medicine, Kidney transplantation, Urology and Surgery.
His studies in Transplantation integrate themes in fields like Immunosuppression, Kidney, Pharmacology and Intensive care medicine.
Klemens Budde has included themes like Gastroenterology, Endocrinology and Oncology in his Internal medicine study.
His Kidney transplantation research incorporates elements of Clinical trial, Randomized controlled trial, Retrospective cohort study, Immunology and Ciclosporin.
The various areas that Klemens Budde examines in his Urology study include Calcineurin, Renal function, Regimen, Tacrolimus and Everolimus.
Surgery is often connected to Kidney disease in his work.
He most often published in these fields:
- Transplantation (37.13%)
- Internal medicine (35.50%)
- Kidney transplantation (31.36%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (35.50%)
- Kidney transplantation (31.36%)
- Transplantation (37.13%)
In recent papers he was focusing on the following fields of study:
Klemens Budde mainly focuses on Internal medicine, Kidney transplantation, Transplantation, Urology and Renal function.
His work in Internal medicine tackles topics such as Gastroenterology which are related to areas like Antibody.
His study on Kidney transplantation is covered under Kidney.
Transplantation is a subfield of Surgery that Klemens Budde investigates.
Klemens Budde combines subjects such as Creatinine and Nephrectomy with his study of Surgery.
His research in Urology intersects with topics in Tuberous sclerosis, Tacrolimus, Biopsy, Everolimus and Proteinuria.
Between 2016 and 2021, his most popular works were:
- Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy : Second Consensus Report (110 citations)
- Biomarkers in acute kidney injury – pathophysiological basis and clinical performance (102 citations)
- Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study (67 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Klemens Budde mostly deals with Kidney transplantation, Transplantation, Internal medicine, Urology and Intensive care medicine.
In the subject of general Kidney transplantation, his work in Antibody mediated rejection is often linked to Outcome, thereby combining diverse domains of study.
His Transplantation study combines topics in areas such as Diabetes mellitus, Immunosuppression, Disease and Quality of life.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Oncology.
The concepts of his Urology study are interwoven with issues in Angiomyolipoma, Renal function, Tuberous sclerosis, Tacrolimus and Everolimus.
His Renal function research includes themes of Clinical endpoint, Proteinuria and Mycophenolic acid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
